Summit Trail Advisors’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Sell
7,828
-2,067
-21% -$269K 0.01% 925
2026
Q1
$1.28M Buy
9,895
+1,611
+19% +$232K 0.02% 812
2025
Q4
$1.18M Sell
8,284
-2,269
-22% -$304K 0.02% 724
2025
Q3
$1.27M Buy
10,553
+6,772
+179% +$858K 0.02% 700
2025
Q2
$500K Buy
+3,781
New +$513K 0.01% 740
2024
Q4
Sell
-1,123
Closed -$205K 552
2024
Q3
$205K Buy
+1,123
New +$166K 0.01% 670

Other funds holding ICUI

Summit Trail Advisors's ICUI Position: Q2 2026 in Review

Summit Trail Advisors reduced its ICU Medical (ICUI) stake by 21% in Q2 2026, selling an estimated $269K and leaving 7,828 shares worth $1.15M. The position accounts for 0.01% of the portfolio, ranked #925.

Summit Trail Advisors first reported a position in ICUI in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.28M in Q1 2026. 289 funds tracked by Wall St. Rank hold ICUI as of Q2 2026.

  • Summit Trail Advisors held 7,828 shares of ICU Medical worth $1.15M as of Q2 2026.
  • Summit Trail Advisors sold 2,067 ICU Medical shares in Q2 2026, an estimated $269K.
  • ICU Medical made up 0.01% of Summit Trail Advisors's portfolio in Q2 2026, its #925 holding.
  • Summit Trail Advisors first reported a position in ICU Medical in Q3 2024 and has held it in 6 quarters since.
  • Summit Trail Advisors's ICU Medical position peaked at $1.28M in Q1 2026.
  • 289 funds tracked by Wall St. Rank held ICU Medical as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.